Journals / Sağlık Bilimlerinde İleri Araştırmalar Dergisi / 2022 / Cilt: 5 - Sayı: 3

CHARACTERIZATION OF MINOR HISTOCOMPATIBILITY ANTIGENS AND THEIR ROLE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE IN TURKEY

MİNÖR DOKU UYGUNLUK ANTİJENLERİNİN KARAKTERİZASYONU VE ALLOGENEİK HEMATOPOETİK KÖK HÜCRE NAKLİNDEKİ ROLÜ: TÜRKİYE’DE TEK MERKEZ DENEYİMİ

Pages
130–134
Publication Date
2022-11-16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We assume that determining the mHAg frequencies in the healthy Turkish population and in patients with malignant hematological diseases will likely contribute to the understanding of the immune response.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The minor histocompatibility antigens (mHAgs) are the epitopes composed of polymorphic essential peptides, and they create T cell response limited to a variety of class I and II HLA alleles.
📊
Key Findings & Data:Material and Methods: The study population included 200 healthy individuals, 150 HLA-typed patients who were candidates for allogeneic HSCT, and 20 recipients/donors with allogeneic transplants.
💡
Conclusion & Impact:Conclusion: We assume that determining the mHAg frequencies in the healthy Turkish population and in patients with malignant hematological diseases will likely contribute to the understanding of the immune response.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Minör Histo Uygunluk Antijenleri · Allojenik Hematopoietik Kök Hücre Nakli · Graft-versus-host hastalığı

Abstract

Objective: The minor histocompatibility antigens (mHAgs) are the epitopes composed of polymorphic essential peptides, and they create T cell response limited to a variety of class I and II HLA alleles. In recent years, there has been extensive research on the distribution of polymorphic regions in different populations. The incompatibility between recipient and donor, may initiate a strong cellular immune response despite HLA full-matched transplantation. We determined the frequency of minor antigens among hematopoietic stem cell transplantation (HSCT) recipients who underwent transplantation for various hematological diseases. Material and Methods: The study population included 200 healthy individuals, 150 HLA-typed patients who were candidates for allogeneic HSCT, and 20 recipients/donors with allogeneic transplants. Minor HAgs identified by using polymerase chain reaction (PCR) and sequence specific primer (SSP) methods. Results: When the allele frequencies and genotypes of the patients were compared with those of the healthy group, the difference was not significant regarding to immunogenic or non-immunogenic allele frequencies. The individuals with immunogenic homozygous H allele (HH genotype) were a few more in the healthy group, and this difference proved to be statistically significant. In fact, our study population Insufficient though the number was, based on the data received from 20 transplant patients and donors, GvHD was observed in 5 of 10 patients who had minor incompatibility. Conclusion: We assume that determining the mHAg frequencies in the healthy Turkish population and in patients with malignant hematological diseases will likely contribute to the understanding of the immune response.

Özet

Amaç: Minör doku uygunluk antijenleri (mHAg), polimorfik esansiyel peptitlerden oluşan epitoplar olup sınıf I ve II HLA allele çeşitleri ile sınırlı olan bir T hücresi yanıtı ortaya çıkarırlar. Son yıllarda, farklı popülasyonlarda polimorfik bölgelerin dağılımı hakkında kapsamlı araştırmalar yapılmıştır. Alıcı ve verici arasındaki mHAg uyumsuzluğu, HLA tam uyumlu transplantasyona rağmen güçlü bir hücresel immün yanıtı başlatabilir. Çalışmamızda çeşitli hematolojik hastalıklar nedeniyle hematopoietik kök hücre transplantasyonu (AKHN) yapılan hastalarda mHAg sıklığının belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Çalışma popülasyonu 200 sağlıklı bireyi, allojenik AKHN adayları olarak HLA’sı tiplendirilmiş olan 150 hastayı ve 20 allojenik AKHN alıcısı/donörünü içermektedir. mHAg’lar, polimeraz zincir reaksiyonu (PZR) ve diziye özgü primer (SSP) yöntemleri kullanılarak belirlendi. Bulgular: Hastaların alel frekansları ve genotipleri sağlıklı grup ile karşılaştırıldığında, immünojenik veya immünojenik olmayan alel frekansları açısından fark anlamlı değildi. Sağlıklı grupta immünojenik homozigot H aleli (HH genotipi) olan bireyler daha azdı ve bu fark istatistiksel olarak anlamlıydı. Çalışma popülasyonumuz küçük olmasına rağmen, 20 transplant hastasından ve donöründen alınan verilere göre, 10 hastanın %50’sinin minör uyumsuzluk kaynaklı Graft versus host hastalığı (GVHH) olduğu gözlendi. Sonuç: Sağlıklı Türk popülasyonunda ve malign hematolojik hastalığı olan hastalarda mHAg frekanslarının belirlenmesinin immün yanıtın anlaşılmasına katkı sağlayacağını düşünmekteyiz.

🔖

Cite This Article

OĞUZ, F. S., KEKİK, Ç., OGUZ, R., KIVANÇ, D., SARGIN, D., KALAYOĞLU-BEŞIŞIK, S. (2022). CHARACTERIZATION OF MINOR HISTOCOMPATIBILITY ANTIGENS AND THEIR ROLE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE IN TURKEY. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, Cilt: 5 - Sayı: 3, 130–134. https://ajindex.com/articles/888377

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL, et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 1998
  2. 279(5353):1054-7. google scholar 2. Schreuder GM, Pool J, Blokland E, van Els C, Bakker A, van Rood JJ, et al: A genetic analysis of human minor histocompatibility antigens demonstrates Mendelian segregation independent of HLA. Immunogenetics 1993
  3. 38(2):98-105. google scholar 3. Chao NJ. Minors come of age: minor histocompatibility antigens and graft-versus-host disease. Biol Blood Marrow Transplant 2004
  4. 10(4):215-23. google scholar 4. Falkenburg JHF, van de Corput L, Marijt EWA, Willemze R. Minor histocompatibility antigens in human stem cell transplantation. Exp Hematol 2003
  5. 31(9):743-51. google scholar 5. Spierings E, Wieles B, Goulmy E. Minor histocompatibility antigens— big in tumour therapy. Trends Immunol 2004
  6. 25(2):56-60. google scholar 6. Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 2004
  7. 4(5):371-80. google scholar 7. Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J, et al. Phenotype Frequencies of Autosomal Minor Histocompatibility Antigens Display Significant Differences among Populations. PLoS Genet 2007
  8. 3(6):103. google scholar 8. Terlizzi SD, Zino E, Mazzi B, Magnani C, Tresoldi C, Perna SK, et al. Therapeutic and Diagnostic Applications of Minor Histocompatibility Antigen HA-1 and HA-2 Disparities in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey of Different Populations. Biol Blood Marrow Transplant 2006:12(1):95-101. google scholar 9. Romaniuk DS, Postovskaya AM, Khmelevskaya AA, Malko DB and Efimov GA. Rapid Multiplex Genotyping of 20 HLA-A*02:01 Restricted Minor Histocompatibility Antigens. Front Immunol 2019
  9. doi: 10.3389/fimmu.2019.01226. google scholar 10. Tseng LH, Lin MT, Martin PJ, Pei J, Smith AG, Hansen JA. Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA. Tissue Antigen 1998
  10. 52(4):305-11. google scholar 11. den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995:9
  11. 268(5216):1476-80. google scholar 12. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, et al. Mismatches of minor histocompatibity antigens between HLA identical donors and recipients a